Osaic Holdings’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,364
Closed -$286 7618
2023
Q2
$286 Hold
1,364
﹤0.01% 7148
2023
Q1
$218 Hold
1,364
﹤0.01% 7254
2022
Q4
$1K Hold
1,364
﹤0.01% 7037
2022
Q3
$1K Sell
1,364
-500
-27% -$539 ﹤0.01% 7159
2022
Q2
$1K Hold
1,864
﹤0.01% 7222
2022
Q1
$2K Hold
1,864
﹤0.01% 6943
2021
Q4
$4K Hold
1,864
﹤0.01% 6819
2021
Q3
$6K Buy
1,864
+1,000
+116% +$3.08K ﹤0.01% 6488
2021
Q2
$2K Hold
864
﹤0.01% 6776
2021
Q1
$3K Buy
864
+500
+137% +$1.67K ﹤0.01% 6428
2020
Q4
$1K Sell
364
-13,812
-97% -$22.8K ﹤0.01% 6315
2020
Q3
$17K Hold
14,176
﹤0.01% 5009
2020
Q2
$13K Hold
14,176
﹤0.01% 5062
2020
Q1
$12K Buy
+14,176
New +$16.4K ﹤0.01% 4919

Other funds holding INFI

Osaic Holdings's INFI Position: Q3 2023 in Review

Osaic Holdings sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2023, closing a stake of 1,364 shares — an estimated $286 sold.

Osaic Holdings first reported a position in INFI in Q1 2020 and held it in 14 quarters. The position peaked at $17K in Q3 2020. 3 funds tracked by Wall St. Rank hold INFI as of Q3 2023.

  • Osaic Holdings reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
  • Osaic Holdings sold 1,364 Infinity Pharmaceuticals, Inc. shares in Q3 2023, an estimated $286.
  • Osaic Holdings first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2020 and held it in 14 quarters.
  • Osaic Holdings's Infinity Pharmaceuticals, Inc. position peaked at $17K in Q3 2020.
  • 3 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2023.

Based on Osaic Holdings's 13F filing for Q3 2023, filed 13 Nov 2023.